MDXG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While MDXG has a great health rating, its profitability is only average at the moment. MDXG may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make MDXG a good candidate for value investing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

MDXG had positive earnings in the past year.
MDXG had a positive operating cash flow in the past year.
In multiple years MDXG reported negative net income over the last 5 years.
In multiple years MDXG reported negative operating cash flow during the last 5 years.

1.2 Ratios

MDXG has a better Return On Assets (12.80%) than 94.48% of its industry peers.
The Return On Equity of MDXG (17.09%) is better than 95.05% of its industry peers.
MDXG's Return On Invested Capital of 15.15% is amongst the best of the industry. MDXG outperforms 95.81% of its industry peers.

		Industry Rank	Sector Rank
ROA	12.8%
ROE	17.09%
ROIC	15.15%

ROA(3y)4.7%

ROA(5y)-7.18%

ROE(3y)1.74%

ROE(5y)-20.73%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 10.38%, MDXG belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
With an excellent Operating Margin value of 13.73%, MDXG belongs to the best of the industry, outperforming 92.95% of the companies in the same industry.
In the last couple of years the Operating Margin of MDXG has remained more or less at the same level.
MDXG's Gross Margin of 81.99% is amongst the best of the industry. MDXG outperforms 85.71% of its industry peers.
MDXG's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	13.73%
PM (TTM)	10.38%
GM	81.99%

OM growth 3YN/A

OM growth 5Y-1.06%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.19%

GM growth 5Y-0.67%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDXG is creating some value.
Compared to 1 year ago, MDXG has more shares outstanding
The number of shares outstanding for MDXG has been increased compared to 5 years ago.
MDXG has a better debt/assets ratio than last year.

2.2 Solvency

MDXG has an Altman-Z score of 8.11. This indicates that MDXG is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MDXG (8.11) is better than 78.86% of its industry peers.
The Debt to FCF ratio of MDXG is 0.27, which is an excellent value as it means it would take MDXG, only 0.27 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.27, MDXG belongs to the best of the industry, outperforming 95.43% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that MDXG is not too dependend on debt financing.
The Debt to Equity ratio of MDXG (0.07) is worse than 61.14% of its industry peers.
Even though the debt/equity ratio score it not favorable for MDXG, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF	0.27
Altman-Z	8.11

ROIC/WACC1.73

WACC8.75%

2.3 Liquidity

MDXG has a Current Ratio of 4.41. This indicates that MDXG is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 4.41, MDXG perfoms like the industry average, outperforming 50.86% of the companies in the same industry.
A Quick Ratio of 3.95 indicates that MDXG has no problem at all paying its short term obligations.
MDXG has a Quick ratio (3.95) which is in line with its industry peers.

		Industry Rank	Sector Rank
Current Ratio	4.41
Quick Ratio	3.95

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for MDXG have decreased strongly by -35.71% in the last year.
Looking at the last year, MDXG shows a quite strong growth in Revenue. The Revenue has grown by 14.77% in the last year.
The Revenue has been growing slightly by 3.11% on average over the past years.

EPS 1Y (TTM)-35.71%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%200%

Revenue 1Y (TTM)14.77%

Revenue growth 3Y10.5%

Revenue growth 5Y3.11%

Sales Q2Q%35.3%

3.2 Future

MDXG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.54% yearly.
Based on estimates for the next years, MDXG will show a quite strong growth in Revenue. The Revenue will grow by 14.49% on average per year.

EPS Next Y47.72%

EPS Next 2Y-7.17%

EPS Next 3Y16.54%

EPS Next 5YN/A

Revenue Next Year18%

Revenue Next 2Y7.11%

Revenue Next 3Y9.76%

Revenue Next 5Y14.49%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.58, MDXG is valued correctly.
96.19% of the companies in the same industry are more expensive than MDXG, based on the Price/Earnings ratio.
MDXG is valuated rather cheaply when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 21.01, MDXG is valued on the expensive side.
Based on the Price/Forward Earnings ratio, MDXG is valued cheaply inside the industry as 93.52% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 25.98. MDXG is around the same levels.

		Industry Rank	Sector Rank
PE	14.58
Fwd PE	21.01

4.2 Price Multiples

97.71% of the companies in the same industry are more expensive than MDXG, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, MDXG is valued cheaper than 98.10% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	11.64
EV/EBITDA	9.52

4.3 Compensation for Growth

MDXG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of MDXG may justify a higher PE ratio.
A more expensive valuation may be justified as MDXG's earnings are expected to grow with 16.54% in the coming years.